| Activation of electrical triggers of atrial fibrillation in hyperthyroidism. | |
| | |
MedLine Citation:
|
PMID: 18349059 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
CONTEXT: A shortening of the atrial refractory period has been considered as the main mechanism for the increased risk of atrial fibrillation in hyperthyroidism. However, other important factors may be involved. OBJECTIVE: Our objective was to determine the activity of abnormal supraventricular electrical depolarizations in response to elevated thyroid hormones in patients without structural heart disease. PATIENTS AND DESIGN: Twenty-eight patients (25 females, three males, mean age 43+/-11 yr) with newly diagnosed and untreated hyperthyroidism were enrolled in a prospective trial after exclusion of heart disease. Patients were followed up for 16 +/- 6 months and studied at baseline and 6 months after normalization of serum TSH levels. MAIN OUTCOME MEASURES: The incidence of abnormal premature supraventricular depolarizations (SVPD) and the number of episodes of supraventricular tachycardia was defined as primary outcome measurements before the start of the study. In addition, heart rate oscillations (turbulence) after premature depolarizations and heart rate variability were compared at baseline and follow-up. RESULTS: SVPDs decreased from 59 +/- 29 to 21 +/- 8 per 24 h (P = 0.003), very early SVPDs (so called P on T) decreased from 36 +/- 24 to 3 +/- 1 per 24 h (P < 0.0001), respectively, and nonsustained supraventricular tachycardias decreased from 22 +/- 11 to 0.5 +/- 0.2 per 24 h (P = 0.01) after normalization of serum thyrotropin levels. The hyperthyroid phase was characterized by an increased heart rate (93 +/- 14 vs. 79 +/- 8 beats/min, P < 0.0001) and a decreased turbulence slope (3.6 vs. 9.2, P = 0.003), consistent with decreased vagal tone. This was confirmed by a significant decrease of heart rate variability. CONCLUSION: Hyperthyroidism is associated with an increased supraventricular ectopic activity in patients with normal hearts. The activation of these arrhythmogenic foci by elevated thyroid hormones may be an important causal link between hyperthyroidism and atrial fibrillation. |
| | |
Authors:
|
K Wustmann; J P Kucera; A Zanchi; A Burow; T Stuber; B Chappuis; P Diem; E Delacrétaz |
Related Documents
:
|
12297719 - Ovarian ultrasound and ovarian and adrenal hormones before and after treatment for hype... 10811699 - Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagno... 19549249 - Short-term overt hypothyroidism induces sympathovagal imbalance in thyroidectomized dif... 17123339 - Recombinant human thyrotropin-assisted radioiodine therapy for patients with metastatic... 18302519 - The prevalence of transient thyrotoxicosis after antithyroid drug therapy in patients w... 10555089 - High prevalence of hypothyroidism in patients with primary pulmonary hypertension. 1090329 - Effects of ambulance transport in critically ill patients. 869349 - Hla b27 in rheumatoid factor-negative polyarthritis. 9146479 - Somatosensory evoked potentials in adults with cortical dysgenesis and epilepsy. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't Date: 2008-03-18 |
Journal Detail:
|
Title: The Journal of clinical endocrinology and metabolism Volume: 93 ISSN: 0021-972X ISO Abbreviation: J. Clin. Endocrinol. Metab. Publication Date: 2008 Jun |
Date Detail:
|
Created Date: 2008-06-09 Completed Date: 2008-07-17 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0375362 Medline TA: J Clin Endocrinol Metab Country: United States |
Other Details:
|
Languages: eng Pagination: 2104-8 Citation Subset: AIM; IM |
Affiliation:
|
Department of Cardiovascular Medicine, Swiss Cardiovascular Center Bern, University Hospital, CH-3010 Bern, Switzerland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Action Potentials
/
physiology* Adult Antithyroid Agents / therapeutic use Atrial Fibrillation / etiology*, physiopathology Carbimazole / therapeutic use Echocardiography Electric Stimulation Female Heart Rate / drug effects, physiology Humans Hyperthyroidism / complications*, drug therapy, physiopathology Male Middle Aged Propylthiouracil / therapeutic use Tachycardia, Supraventricular / etiology |
| Chemical | |
Reg. No./Substance:
|
0/Antithyroid Agents; 22232-54-8/Carbimazole; 51-52-5/Propylthiouracil |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Rab18 is reduced in pituitary tumors causing acromegaly and its overexpression reverts growth hormon...
Next Document: Insulin-stimulated rates of glucose uptake in muscle in hyperthyroidism: the importance of blood flo...